Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibeshih Belachew

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Cell Cycle (Georgetown, Tex.)|December 13, 2007
CDK2 is dispensable for adult hippocampal neurogenesisRenaud Vandenbosch, Laurence Borgs, Pierre Beukelaers, et al.
Neuropharmacology|December 25, 2004
Beta-carbolines induce apoptosis in cultured cerebellar granule neurons via the mitochondrial pathwayGrégory Hans, Brigitte Malgrange, François Lallemend, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2018
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trialEdward J Fox, Clyde Markowitz, Angela Applebee, et al.
Neurorehabilitation and Neural Repair|March 26, 2011
Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosisRémy Phan-Ba, Amy Pace, Philippe Calay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2022
Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosisIh Chang, Ludwig Kappos, Gavin Giovannoni, et al.
Brain : a Journal of Neurology|September 10, 2019
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosisColm Elliott, Shibeshih Belachew, Jerry S Wolinsky, et al.
Annals of Clinical and Translational Neurology|December 23, 2022
Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosisJennifer S Graves, Marco Ganzetti, Frank Dondelinger, et al.
Annals of Neurology|August 30, 2018
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trialJerry S Wolinsky, Xavier Montalban, Stephen L Hauser, et al.
JAMA Neurology|June 9, 2020
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical TrialsLudwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, et al.
Mechanisms of Development|February 19, 2002
Proliferative generation of mammalian auditory hair cells in cultureBrigitte Malgrange, Shibeshih Belachew, Marc Thiry, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Cell Cycle (Georgetown, Tex.)|December 13, 2007
CDK2 is dispensable for adult hippocampal neurogenesisRenaud Vandenbosch, Laurence Borgs, Pierre Beukelaers, et al.
Neuropharmacology|December 25, 2004
Beta-carbolines induce apoptosis in cultured cerebellar granule neurons via the mitochondrial pathwayGrégory Hans, Brigitte Malgrange, François Lallemend, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 13, 2018
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trialEdward J Fox, Clyde Markowitz, Angela Applebee, et al.
Neurorehabilitation and Neural Repair|March 26, 2011
Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosisRémy Phan-Ba, Amy Pace, Philippe Calay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2022
Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosisIh Chang, Ludwig Kappos, Gavin Giovannoni, et al.
Brain : a Journal of Neurology|September 10, 2019
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosisColm Elliott, Shibeshih Belachew, Jerry S Wolinsky, et al.
Annals of Clinical and Translational Neurology|December 23, 2022
Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosisJennifer S Graves, Marco Ganzetti, Frank Dondelinger, et al.
Annals of Neurology|August 30, 2018
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trialJerry S Wolinsky, Xavier Montalban, Stephen L Hauser, et al.
JAMA Neurology|June 9, 2020
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical TrialsLudwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, et al.
Mechanisms of Development|February 19, 2002
Proliferative generation of mammalian auditory hair cells in cultureBrigitte Malgrange, Shibeshih Belachew, Marc Thiry, et al.
Pageof 9